CXCL8 can be induced by hypoxia even in HIF-1-deficient CRC cells as a compensatory pathway of VEGF to preserve tumor angiogenesis, suggesting the potential for combination regimens that target both HIF-1 and CXCL8 [79]. This evidence concerns the gene CXCL8 and colorectal carcinoma.